BR112016022607B8 - Pó e método para aprimorar a aplicação tópica de minoxidil - Google Patents
Pó e método para aprimorar a aplicação tópica de minoxidilInfo
- Publication number
- BR112016022607B8 BR112016022607B8 BR112016022607A BR112016022607A BR112016022607B8 BR 112016022607 B8 BR112016022607 B8 BR 112016022607B8 BR 112016022607 A BR112016022607 A BR 112016022607A BR 112016022607 A BR112016022607 A BR 112016022607A BR 112016022607 B8 BR112016022607 B8 BR 112016022607B8
- Authority
- BR
- Brazil
- Prior art keywords
- powder
- active ingredient
- topical application
- minoxidil
- capsule
- Prior art date
Links
- 230000000699 topical effect Effects 0.000 title abstract 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 title 1
- 229960003632 minoxidil Drugs 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000002775 capsule Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/652—The particulate/core comprising organic material
Abstract
COMPOSIÇÕES E MÉTODO PARA MELHORAR A APLICAÇÃO TÓPICA DE UM AGENTE DE BENEFÍCIO BÁSICO. A presente invenção se refere a um pó que inclui partículas de núcleo/cápsula que têm um tamanho médio de partícula menor que 1000 mícrons, sendo que cada partícula contém um núcleo líquido que é substancialmente isento de água e inclui A) um líquido polar tendo um percentual de polaridade de superfície de ao menos 24%, um ingrediente ativo básico, e C) de cerca de 0,1% a cerca de 20%, em peso de ao menos um agente intensificador de solubilidade ácido que não é um ingrediente ativo; e uma cápsula que compreende partículas hidrofóbicas. O pó pode ser usado para administrar topicamente o ingrediente ativo a um ser humano ou animal.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/230,565 | 2014-03-31 | ||
US14/230,565 US9474699B2 (en) | 2014-03-31 | 2014-03-31 | Compostions and methods for enhancing the topical application of a basic benefit agent |
PCT/US2015/019589 WO2015153074A1 (en) | 2014-03-31 | 2015-03-10 | Compositions and methods for enhancing the topical application of a basic benefit agent |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016022607B1 BR112016022607B1 (pt) | 2021-01-19 |
BR112016022607B8 true BR112016022607B8 (pt) | 2022-08-30 |
Family
ID=52785154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016022607A BR112016022607B8 (pt) | 2014-03-31 | 2015-03-10 | Pó e método para aprimorar a aplicação tópica de minoxidil |
Country Status (8)
Country | Link |
---|---|
US (1) | US9474699B2 (pt) |
EP (1) | EP3125857B1 (pt) |
CN (2) | CN106456476B (pt) |
BR (1) | BR112016022607B8 (pt) |
CA (1) | CA2943368C (pt) |
ES (1) | ES2719575T3 (pt) |
RU (1) | RU2722783C2 (pt) |
WO (1) | WO2015153074A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9475709B2 (en) | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
US10980919B2 (en) | 2016-04-14 | 2021-04-20 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
TW201504140A (zh) | 2013-03-12 | 2015-02-01 | Lockheed Corp | 形成具有均勻孔尺寸之多孔石墨烯之方法 |
CA2938273A1 (en) | 2014-01-31 | 2015-08-06 | Peter V. Bedworth | Perforating two-dimensional materials using broad ion field |
WO2015116857A2 (en) | 2014-01-31 | 2015-08-06 | Lockheed Martin Corporation | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
JP2017512129A (ja) | 2014-03-12 | 2017-05-18 | ロッキード・マーチン・コーポレーション | 有孔グラフェンから形成された分離膜 |
KR20170095804A (ko) | 2014-09-02 | 2017-08-23 | 록히드 마틴 코포레이션 | 이차원 막 소재에 기반을 둔 혈액 투석 및 혈액 여과 막과 이를 이용하는 방법 |
EP3219773B1 (en) * | 2014-11-11 | 2019-05-08 | National Institute for Materials Science | Film-forming composition including tannic acid derivative |
CA2994549A1 (en) | 2015-08-05 | 2017-02-09 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
KR20180037991A (ko) | 2015-08-06 | 2018-04-13 | 록히드 마틴 코포레이션 | 그래핀의 나노 입자 변형 및 천공 |
CA3020686A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Method for treating graphene sheets for large-scale transfer using free-float method |
WO2017180141A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Selective interfacial mitigation of graphene defects |
EP3443329A4 (en) | 2016-04-14 | 2020-04-08 | Lockheed Martin Corporation | METHODS FOR PROVIDING IN SITU MONITORING AND CONTROL OF DEFECT TRAINING OR HEALING |
EP3442786A4 (en) | 2016-04-14 | 2020-03-18 | Lockheed Martin Corporation | TWO-DIMENSIONAL MEMBRANE STRUCTURES HAVING FLOW PASSAGES |
WO2017180135A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Membranes with tunable selectivity |
BR112019011257B1 (pt) * | 2016-12-01 | 2022-08-23 | 3M Innovative Properties Company | Composição dental compreendendo material encapsulado e método para fabricação do material encapsulado |
US10596134B2 (en) * | 2017-02-08 | 2020-03-24 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating skin conditions using light and polycarboxylic acids |
CN110785161B (zh) | 2017-06-23 | 2023-06-20 | 宝洁公司 | 用于改善皮肤外观的组合物和方法 |
CN112437657A (zh) | 2018-07-03 | 2021-03-02 | 宝洁公司 | 处理皮肤状况的方法 |
CN115843238A (zh) | 2020-06-01 | 2023-03-24 | 宝洁公司 | 改善维生素b3化合物渗透到皮肤中的方法 |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
CN114788788B (zh) * | 2022-05-09 | 2023-08-01 | 无锡知妍生物科技有限公司 | 一种二硫化硒包裹技术及二硫化硒洗发水 |
US11951082B2 (en) | 2022-08-22 | 2024-04-09 | Ford Therapeutics, Llc | Composition of chlorhexidine |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1467023A1 (de) | 1964-02-28 | 1969-01-23 | Degussa | Verfahren zur Inkorporierung von Wasser in feinst verteilter Kieselsaeure |
DE2844052A1 (de) | 1978-10-10 | 1980-04-30 | Degussa | Waessrige dispersion einer hydrophoben kieselsaeure |
US5229076A (en) | 1992-05-08 | 1993-07-20 | Fagher Richard H | Method for reducing polymer build-up in a polymerization reactor |
US6174533B1 (en) | 1997-05-23 | 2001-01-16 | The Procter & Gamble Company | Skin care compositions and method of improving skin appearance |
AUPP310798A0 (en) | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
EP0964054A1 (en) | 1998-06-11 | 1999-12-15 | Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) | Surface-active alkylurethanes of fructans |
US6284234B1 (en) | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
US20020006418A1 (en) | 1998-10-13 | 2002-01-17 | John Kung | Composition to enhance permeation of topical skin agents |
FR2785539B1 (fr) * | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Particules enrobees d'ibuprofene cristallin granule |
JP2000309505A (ja) | 1999-02-26 | 2000-11-07 | Shiseido Co Ltd | 粉末化粧料 |
US6290941B1 (en) | 1999-11-23 | 2001-09-18 | Color Access, Inc. | Powder to liquid compositions |
WO2001078662A1 (fr) * | 2000-04-07 | 2001-10-25 | Taisho Pharmaceutical Co. Ltd. | Compositions de toniques capillaires a action durable |
US6413548B1 (en) | 2000-05-10 | 2002-07-02 | Aveka, Inc. | Particulate encapsulation of liquid beads |
US20040028710A1 (en) | 2001-01-18 | 2004-02-12 | Takashi Oka | Process for producing dry water |
US7914811B2 (en) * | 2001-06-29 | 2011-03-29 | Mcneil-Ppc, Inc. | Brittle-coating, soft core dosage form |
FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
US20050220860A1 (en) | 2002-04-15 | 2005-10-06 | Kim Dong Y | Stabilized pure vitamin-C in powder to liquid form using multi-encapsulation method |
WO2004016720A2 (en) * | 2002-08-14 | 2004-02-26 | E.I. Du Pont De Nemours And Company | Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles |
US7477939B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating a wound with galvanic generated electricity |
US7477940B2 (en) | 2003-06-30 | 2009-01-13 | J&J Consumer Companies, Inc. | Methods of administering an active agent to a human barrier membrane with galvanic generated electricity |
US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
US7476222B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of reducing the appearance of pigmentation with galvanic generated electricity |
US20050084510A1 (en) | 2003-10-20 | 2005-04-21 | Carson John C. | Water in oil formulations, method to prepare same, and personal care products formed using same |
CN1886113A (zh) | 2003-12-01 | 2006-12-27 | 德古萨股份公司 | 具有高水分含量的可刷化妆制品 |
US20050163811A1 (en) * | 2004-01-23 | 2005-07-28 | Richard Lee | Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof |
US20060008485A1 (en) | 2004-07-12 | 2006-01-12 | Ferone James J | Packaged cosmetic compositions and related methods |
DE102004056862A1 (de) | 2004-11-25 | 2006-06-14 | Degussa Ag | Pulverförmige, kosmetische Zubereitung mit hohem Wassergehalt |
DE102005055226A1 (de) | 2004-12-24 | 2006-07-13 | Degussa Ag | Lagerung pulverförmiger Stoffe mit hohem Wassergehalt |
ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
US20070154426A1 (en) | 2006-01-05 | 2007-07-05 | Hansen Angela M | Powdered water cosmetic compositions and related methods |
US7417020B2 (en) | 2006-05-05 | 2008-08-26 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising low-DP polymerized surfactants and methods of use thereof |
US20080038557A1 (en) | 2006-08-08 | 2008-02-14 | The Procter & Gamble Company | Process for making collapsible water-containing capsules |
ITMI20061692A1 (it) * | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
US7704533B2 (en) | 2006-12-13 | 2010-04-27 | J&J Consumer Companies, Inc. | Compositions and methods of inducing hair growth utilizing Continus coggygria |
TWI411448B (zh) | 2007-12-27 | 2013-10-11 | Avon Prod Inc | 適合用於化妝品之光學模糊色素組合物 |
KR101355695B1 (ko) | 2009-02-06 | 2014-01-27 | 더 프록터 앤드 갬블 캄파니 | 붕괴성 수분-함유 캡슐 |
US20100268335A1 (en) | 2009-03-27 | 2010-10-21 | Chunlin Yang | Medical devices with galvanic particulates |
US8399590B2 (en) | 2009-10-07 | 2013-03-19 | Akzo Nobel Chemicals International B.V. | Superhydrophilic amphiphilic copolymers and processes for making the same |
US8258250B2 (en) | 2009-10-07 | 2012-09-04 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof |
US8545821B2 (en) | 2009-11-05 | 2013-10-01 | Avon Products, Inc. | Cosmetic use of water-redispersible powders |
US9793199B2 (en) | 2009-12-18 | 2017-10-17 | Ati Technologies Ulc | Circuit board with via trace connection and method of making the same |
US8647653B2 (en) * | 2009-12-26 | 2014-02-11 | Evonik Degussa Gmbh | Water containing powder composition |
KR20110091461A (ko) | 2010-02-05 | 2011-08-11 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 갈바니 미립자를 포함하는 립 조성물 |
BR112013001691A2 (pt) | 2010-07-23 | 2016-05-24 | Johnson & Johnson Consumer | particulados de metal geradores de corrente de corrosão e uso dos mesmos |
DE102011077298A1 (de) | 2011-06-09 | 2012-12-13 | Evonik Degussa Gmbh | Kern-Hülle-Partikel mit einem hohen Gehalt an Glycerin, ihre Herstellung und Verwendung |
DE102011088840A1 (de) | 2011-12-16 | 2013-06-20 | Henkel Ag & Co. Kgaa | Pulverförmige Haarkosmetika |
KR20150095924A (ko) | 2012-12-19 | 2015-08-21 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 무수 분말-액체 입자 |
-
2014
- 2014-03-31 US US14/230,565 patent/US9474699B2/en active Active
-
2015
- 2015-03-10 ES ES15712467T patent/ES2719575T3/es active Active
- 2015-03-10 EP EP15712467.8A patent/EP3125857B1/en active Active
- 2015-03-10 RU RU2016142479A patent/RU2722783C2/ru active
- 2015-03-10 CA CA2943368A patent/CA2943368C/en active Active
- 2015-03-10 WO PCT/US2015/019589 patent/WO2015153074A1/en active Application Filing
- 2015-03-10 CN CN201580017164.8A patent/CN106456476B/zh active Active
- 2015-03-10 BR BR112016022607A patent/BR112016022607B8/pt active IP Right Grant
- 2015-03-10 CN CN201910808394.6A patent/CN110403833B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CA2943368A1 (en) | 2015-10-08 |
CN106456476B (zh) | 2019-08-27 |
EP3125857B1 (en) | 2019-02-27 |
WO2015153074A1 (en) | 2015-10-08 |
RU2016142479A3 (pt) | 2018-10-08 |
RU2016142479A (ru) | 2018-05-03 |
BR112016022607B1 (pt) | 2021-01-19 |
ES2719575T3 (es) | 2019-07-11 |
CA2943368C (en) | 2022-03-15 |
RU2722783C2 (ru) | 2020-06-03 |
CN106456476A (zh) | 2017-02-22 |
US20150272834A1 (en) | 2015-10-01 |
EP3125857A1 (en) | 2017-02-08 |
CN110403833A (zh) | 2019-11-05 |
US9474699B2 (en) | 2016-10-25 |
CN110403833B (zh) | 2022-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016022607B8 (pt) | Pó e método para aprimorar a aplicação tópica de minoxidil | |
BR112016022159B8 (pt) | Pó e método para melhorar a aplicação tópica de um agente de benefício ácido | |
BR112015014831A2 (pt) | partículas anidras de pó a líquido | |
BR122021018243A8 (pt) | Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável | |
BR112015023340A8 (pt) | dispersões submicrômetras, substancialmente livres de tensoativo, de agentes hidrofóbicos contendo altos níveis de solvente miscível em água | |
IN2015MU00865A (pt) | ||
MX2018006919A (es) | Composiciones de emulsion inversas. | |
CA2934086C (en) | Finisher composition comprising silicone microparticles and non-volatile oil | |
BR112015023321A2 (pt) | dispersões submicrômetras substancialmente livres de surfactante e alimento com as mesmas | |
BR112015020302A2 (pt) | derivado de pirazol | |
BR112018011210A2 (pt) | métodos para inibir a conversão de carnitina em trimetilamina (tma) | |
PE20171334A1 (es) | Formulacion en polvo nasal para el tratamiento de hipoglicemia | |
BR112018074352A2 (pt) | partículas de nanoalume contendo um agente de dimensionamento | |
BR112017013484A2 (pt) | processo para preparação de partículas de bicarbonato de metais alcalinos, partículas de bicarbonato de metal alcalino, e, usos de partículas de bicarbonato de metal alcalino e de um ácido de resina ou um ácido graxo ou uma cera. | |
MA43918A (fr) | Composition pharmaceutique pour la prã‰vention et/ou le traitement de la dermatite atopique contenant comme principe actif un antagoniste de l'il-31 | |
BR112016015851A2 (pt) | Formulações farmacêuticas estabilizadas de insulina aspart | |
BR112018012952A2 (pt) | composições para higiene pessoal | |
EA201592279A1 (ru) | Фармацевтическая композиция, ее получение и применение | |
BR112016025126A2 (pt) | formulação líquida compreendendo composto neutralizante de gm-csf | |
BR112018011157A2 (pt) | composição agroquímica de suspensão aquosa. | |
NZ732529A (en) | Microencapsulated nitrification inhibitor compositions | |
BR112017024735A2 (pt) | suspensão e emulsão de microcápsula e seu método de produção | |
CL2018003110A1 (es) | Preparación y dispersión de formulaciones de emulsión estable. | |
BR102015006886B8 (pt) | Composição tópicas que compreendem 4-hexilresorcinol e pós e uso | |
BR112016029317A2 (pt) | composições e métodos para melhorar a aplicação tópica de um cosmético colorido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved |
Owner name: CHENANGO ZERO LLC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: CHENANGO TWO LLC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: CURRAHEE HOLDING COMPANY INC. (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US) |
|
B25A | Requested transfer of rights approved |
Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US) |